1.16
-0.04(-3.33%)
Currency In USD
| Previous Close | 1.2 |
| Open | 1.17 |
| Day High | 1.19 |
| Day Low | 1.16 |
| 52-Week High | 14.4 |
| 52-Week Low | 1.08 |
| Volume | 12,054 |
| Average Volume | 3.58M |
| Market Cap | 9.1M |
| PE | 0.02 |
| EPS | 56.32 |
| Moving Average 50 Days | 1.39 |
| Moving Average 200 Days | 2 |
| Change | -0.04 |
If you invested $1000 in Ernexa Therapeutics Inc. (ERNA) 10 years ago, it would be worth $0.24 as of January 05, 2026 at a share price of $1.16. Whereas If you bought $1000 worth of Ernexa Therapeutics Inc. (ERNA) shares 5 years ago, it would be worth $0.84 as of January 05, 2026 at a share price of $1.16.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Ernexa Therapeutics Presents New Preclinical Data at American Society of Hematology (ASH) Annual Meeting on Lead Cell Therapy Candidate for Treatment of Ovarian Cancer
GlobeNewswire Inc.
Dec 08, 2025 1:30 PM GMT
Positive results of ERNA-101 in ovarian cancer models demonstrated promising survival benefit and immune activation, underscoring the potential for broad oncology applications, including hematologic malignanciesCAMBRIDGE, Mass., Dec. 08, 2025 (GLOB
Ernexa Therapeutics Announces Oral Presentation at the 67th American Society of Hematology (ASH) Annual Meeting
GlobeNewswire Inc.
Dec 03, 2025 1:30 PM GMT
CAMBRIDGE, Mass., Dec. 03, 2025 (GLOBE NEWSWIRE) -- Ernexa Therapeutics (Nasdaq: ERNA), an industry innovator developing novel cell therapies for the treatment of advanced cancer and autoimmune disease, today announced that data from its novel cell
Ernexa Therapeutics Strengthens Scientific and Medical Advisory Board with Appointment of Leading Oncologist Dr. Ira S. Winer, M.D., Ph.D., FACOG
GlobeNewswire Inc.
Dec 02, 2025 1:50 PM GMT
Appointment reinforces clinical and translational depth as Ernexa advances its best-in-class iMSC cell therapy platform into first-in-human trialsCAMBRIDGE, Mass., Dec. 02, 2025 (GLOBE NEWSWIRE) -- Ernexa Therapeutics (Nasdaq: ERNA), an industry in